Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

Also called NCT04061824

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose other
Phase
Phase 4
Enrolled
  • 150 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04061824
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04061824. Randomized; no masking; primary purpose other. Start 2016-05-24 (actual); primary completion 2018-12-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia
Condition
Hypertension
Condition
Dyslipidemias
Intervention (Drug)
Olostar Tab (olmesartan/rosuvastatin FDC(fixed dose combination))
Intervention (Drug)
Two separated drugs(ARB(Angiotensin Ⅱ receptor blocker) and statin)
Lead sponsor
Yonsei University (class: other)

Record details

Record id
cardio:ct-nct04061824
Content hash
f929eb61f89f58ea91359c6d3b93b9c6586b5d1c7b44b29e471c57e74e94caa4